Raghu G - Search Results

1

Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Raghu G, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE Jr. du Bois RM, et al. Among authors: raghu g. Am J Respir Crit Care Med. 2011 Aug 15;184(4):459-66. doi: 10.1164/rccm.201011-1790OC. Am J Respir Crit Care Med. 2011. PMID: 21616999

2

Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial.

Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, Hutchinson J, Pardee NE, Winterbauer RH. Raghu G, et al. Am Rev Respir Dis. 1991 Aug;144(2):291-6. doi: 10.1164/ajrccm/144.2.291. Am Rev Respir Dis. 1991. PMID: 1859050 Clinical Trial.

3

Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

Tobin RW, Pope CE 2nd, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Tobin RW, et al. Among authors: raghu g. Am J Respir Crit Care Med. 1998 Dec;158(6):1804-8. doi: 10.1164/ajrccm.158.6.9804105. Am J Respir Crit Care Med. 1998. PMID: 9847271

4

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study.

Raghu G, Johnson WC, Lockhart D, Mageto Y. Raghu G, et al. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1061-9. doi: 10.1164/ajrccm.159.4.9805017. Am J Respir Crit Care Med. 1999. PMID: 10194146 Clinical Trial.

5

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr; Idiopathic Pulmonary Fibrosis Study Group. Raghu G, et al. N Engl J Med. 2004 Jan 8;350(2):125-33. doi: 10.1056/NEJMoa030511. N Engl J Med. 2004. PMID: 14711911 Clinical Trial.

6

Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?

Flaherty KR, King TE Jr, Raghu G, Lynch JP 3rd, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, Murray S, Lama VN, Gay SE, Martinez FJ. Flaherty KR, et al. Among authors: raghu g. Am J Respir Crit Care Med. 2004 Oct 15;170(8):904-10. doi: 10.1164/rccm.200402-147OC. Epub 2004 Jul 15. Am J Respir Crit Care Med. 2004. PMID: 15256390

7

Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects.

Brown KK, Raghu G. Brown KK, et al. Among authors: raghu g. Clin Chest Med. 2004 Dec;25(4):759-72, vii. doi: 10.1016/j.ccm.2004.08.003. Clin Chest Med. 2004. PMID: 15564021 Review.

8

The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis.

Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. Hallstrand TS, et al. Among authors: raghu g. Eur Respir J. 2005 Jan;25(1):96-103. doi: 10.1183/09031936.04.00137203. Eur Respir J. 2005. PMID: 15640329

9

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

King TE Jr, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, Schwartz DA. King TE Jr, et al. Among authors: raghu g. Chest. 2005 Jan;127(1):171-7. doi: 10.1378/chest.127.1.171. Chest. 2005. PMID: 15653980

10

High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE Jr, Bradford WZ, Schwartz DA, Richard Webb W; Idiopathic Pulmonary Fibrosis Study Group. Lynch DA, et al. Among authors: raghu g. Am J Respir Crit Care Med. 2005 Aug 15;172(4):488-93. doi: 10.1164/rccm.200412-1756OC. Epub 2005 May 13. Am J Respir Crit Care Med. 2005. PMID: 15894598 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results